Gevokizumab in type 1 diabetes mellitus: extreme remedies for extreme diseases?
about
Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease.Immunotherapies currently in development for the treatment of type 1 diabetes.The role of inflammatory biomarkers in developing targeted cardiovascular therapies: lessons from the cardiovascular inflammation reduction trials.Addressing Unmet Medical Needs in Type 1 Diabetes: A Review of Drugs under Development.Pharmacokinetic and pharmacodynamic drug evaluation of tofogliflozin for the treatment of type 2 diabetes.Dapagliflozin for the treatment of type 1 diabetes mellitus.
P2860
Gevokizumab in type 1 diabetes mellitus: extreme remedies for extreme diseases?
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Gevokizumab in type 1 diabetes mellitus: extreme remedies for extreme diseases?
@en
type
label
Gevokizumab in type 1 diabetes mellitus: extreme remedies for extreme diseases?
@en
prefLabel
Gevokizumab in type 1 diabetes mellitus: extreme remedies for extreme diseases?
@en
P2860
P1476
Gevokizumab in type 1 diabetes mellitus: extreme remedies for extreme diseases?
@en
P2093
Kalliopi Pafili
Nikolaos Papanas
P2860
P304
P356
10.1517/13543784.2014.947026
P407
P577
2014-07-31T00:00:00Z